NCT05514990 2025-11-14Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH TrialUniversity of Southern CaliforniaPhase 1/2 Active not recruiting10 enrolled